• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE® 2000 HUMAN CHORIONIC GONADOTROPIN (HCG)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE® 2000 HUMAN CHORIONIC GONADOTROPIN (HCG) Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/16/2021
Event Type  malfunction  
Manufacturer Narrative
An outside of the united states (ous) customer obtained falsely elevated human chorionic gonadotropin (hcg) results on multiple patient samples using lot 466 on the immulite 2000 xpi instrument.Preventative maintenance was performed on the instrument.Additionally, the probe and dual resolution dilutors (drd) alignments and connections on the instrument were checked.A water test was also processed and a precision test was performed using patient samples.The probes were also cleaned and a system check was performed.Furthermore, the customer's handling of kits, adjustments, quality control material, and samples were also reviewed and the instrument was decontaminated.The instrument was performing within specifications.Siemens is investigating the issue.Mdrs: 1219913-2022-00061, 1219913-2022-00062, 1219913-2022-00063, 1219913-2022-00064, 1219913-2022-00065, 1219913-2022-00067 and 1219913-2022-00068 were filed for the same event.
 
Event Description
Falsely elevated human chorionic gonadotropin (hcg) results were obtained on four patient samples on immulite 2000 xpi instrument.The discordant results were not reported to the physician(s).Three samples were repeated on the same instrument, recovering falsely elevated.The samples were also repeated on an alternate (non-siemens) instrument.The results obtained on the alternate instrument recovered lower than the initial results.The repeat results from the alternate (non-siemens) instrument were reported, as the correct results, to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the falsely elevated hcg result.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2022-00066 on 21-feb-2022.Additional information (b)(6) 2022): siemens healthcare diagnostics further investigated the issue and confirmed the potential for falsely elevated human chorionic gonadotropin (hcg) results due to sample carryover.This can be observed when a sample is assayed for hcg immediately after an undiluted sample with a hcg value of 5000 miu/ml.This issue impacts serum and urine patient samples, as well as quality control samples and adjustors.The effect of carryover varies based on the concentration of the high hcg sample.Starting (b)(6) 2022, an urgent medical device correction (umdc, letter imc22-04.A.Us) was sent to us customers, and an urgent field safety notice (ufsn, letter imc22-04.A.Ous) was sent to outside the us (ous).The umdc and ufsn explain the potential for carryover from high hcg samples into the next sample assayed for hcg on the immulite 2000/immulite 2000 xpi, and provides instructions to the customers.The component code, type of investigation, investigation findings and investigation conclusion codes in section h6 and section h9 were updated based on the additional information.Mdrs 1219913-2022-00061_s1, 1219913-2022-00062_s1, 1219913-2022-00063_s1, 1219913-2022-00064_s1, 1219913-2022-00065_s1, 1219913-2022-00067_s1 and 1219913-2022-00068_s1 were filed for the same event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE® 2000 HUMAN CHORIONIC GONADOTROPIN (HCG)
Type of Device
IMMULITE® 2000 HUMAN CHORIONIC GONADOTROPIN (HCG)
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
glyn rhonwy llanberis
gwynedd, LL554 EL
UK  LL554EL
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
glyn rhonwy llanberis
uk registration #: 3002806944
gwynedd, LL554 EL
UK   LL554EL
Manufacturer Contact
kristin kehyaian
511 benedict avenue
tarrytown, NY 10591
9148267101
MDR Report Key13573535
MDR Text Key288122024
Report Number1219913-2022-00066
Device Sequence Number1
Product Code DHA
UDI-Device Identifier00630414961132
UDI-Public00630414961132
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K990222
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2022
Device Model NumberN/A
Device Catalogue Number10381206
Device Lot Number466
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/22/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number2432235-03/04/2022-002-C
Patient Sequence Number1
-
-